+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

From
From
P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 - Product Thumbnail Image

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021

  • Report
  • November 2021
  • 70 Pages
  • Global
From
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020 - Product Thumbnail Image

Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 114 Pages
  • Global
From
Glucagon Like Peptide 2 Receptor - Pipeline Review, H2 2020 - Product Thumbnail Image

Glucagon Like Peptide 2 Receptor - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 67 Pages
  • Global
From
Transthyretin - Pipeline Review, H2 2020 - Product Thumbnail Image

Transthyretin - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 116 Pages
  • Global
From
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020 - Product Thumbnail Image

5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 62 Pages
  • Global
From
Guillain-Barre Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Guillain-Barre Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 84 Pages
  • Global
From
Traumatic Brain Injury - Pipeline Review, H2 2020 - Product Thumbnail Image

Traumatic Brain Injury - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 440 Pages
  • Global
From
Cerebral Palsy - Pipeline Review, H2 2020 - Product Thumbnail Image

Cerebral Palsy - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 50 Pages
  • Global
From
Beta Nerve Growth Factor - Pipeline Review, H2 2020 - Product Thumbnail Image

Beta Nerve Growth Factor - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 61 Pages
  • Global
From
Huntington Disease - Pipeline Review, H1 2020 - Product Thumbnail Image

Huntington Disease - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 390 Pages
  • Global
From
Multiple Sclerosis: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Multiple Sclerosis: Dynamic Market Forecast to 2026

  • Report
  • November 2018
  • 53 Pages
  • Global
From
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more